Faeth Therapeutics (FTH) Cash & Equivalents (2020 - 2026)
Faeth Therapeutics (FTH) reported Cash & Equivalents of $26.9 million for Q2 2026, up 114.2% from $12.56 million a year earlier but down 82.3% from the prior quarter.
Faeth Therapeutics (FTH) Cash & Equivalents (2020 - 2026) Analysis & Trends
At the end of FY2025, Faeth Therapeutics posted Cash & Equivalents of $8.67 million, down 13.3% from FY2024.
- Cash & Equivalents has declined for three consecutive years, with a five-year compound annual growth rate of -12.2% (FY2020 to FY2025).
- By year, Cash & Equivalents came in at $9.99 million in FY2024 (-23.2%), $13.01 million in FY2023 (-26.9%), $17.8 million in FY2022 (+148.6%) and $7.16 million in FY2021 (-56.9%).
- Five-year quarterly Cash & Equivalents spans a low of $7.16 million in Q4 2021 and a high of $152.33 million in Q1 2026.
- Year over year, Cash & Equivalents gained in three of the last seven quarters, with growth averaging 13.9%.
- The high point for year-over-year Cash & Equivalents in five years was Q4 2022 (growth of 148.6%); the low point was Q1 2022 (a decline of 94.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $152.33 million (Q1 2026), $8.67 million (Q4 2025) and $10.56 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,170.64 Bn | 1,139.23 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 647.91 Bn | 567.77 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 503.02 Bn | 476.13 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 365.11 Bn | 319.49 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 303.38 Bn | 267.37 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 268.87 Bn | 242.56 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 242.01 Bn | 197.41 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.74 Bn | 168.94 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 172.37 Bn | 119.01 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Faeth Therapeutics | 116.87 Mn | -318.59 Mn | - | 26.90 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 26.90 Mn |
| Mar 31, 2026 | 152.33 Mn |
| Dec 31, 2025 | 8.67 Mn |
| Sep 30, 2025 | 10.56 Mn |
| Jun 30, 2025 | 12.56 Mn |
| Mar 31, 2025 | 9.88 Mn |
| Dec 31, 2024 | 9.99 Mn |
| Sep 30, 2024 | 19.13 Mn |
| Jun 30, 2024 | 11.89 Mn |
| Mar 31, 2024 | 10.96 Mn |
| Dec 31, 2023 | 13.01 Mn |
| Sep 30, 2023 | 11.34 Mn |
| Jun 30, 2023 | 10.23 Mn |
| Mar 31, 2023 | 8.11 Mn |
| Dec 31, 2022 | 17.80 Mn |
| Sep 30, 2022 | 11.45 Mn |
| Jun 30, 2022 | 9.90 Mn |
| Mar 31, 2022 | 8.72 Mn |
| Dec 31, 2021 | 7.16 Mn |
| Sep 30, 2021 | 9.53 Mn |
Faeth Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=FTH&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "FTH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=FTH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();